Summarized by Masters of Longevity from Longevity Docs News.
Human imaging and lab research that investigates how common medications relate to brown fat activity, offering leads for clinicians and researchers.
Key Takeaways
- 8,897 of 101,243 clinical 18F-FDG PET/CT scans showed detectable brown fat activity.
- ARB prescriptions were associated with higher brown fat signals while SSRI use correlated with lower signals.
- Losartan increased brown fat activity in mouse and cell models, but no randomized human trial has tested this effect.
